AI Analysis

How does BALAXI.NS make money? Does BALAXI.NS have pricing power? What's the Earnings Whisper? Will BALAXI.NS profit more as the business scales? What is BALAXI.NS's management track record? Is BALAXI.NS's current price justified?

Balaxi Pharmaceuticals Limited

₹22.09 -$6.20 (-21.92%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹22.13

Day Range

₹21.8₹22.6

Year Range

₹15.2₹43.85

Market Cap

1.22B

AVG Volume

34.17K

Trailing/Forward PE

49.09/-

PEG ratio

-0.57

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

BALAXI.NS Revenue (INR) by year
Period	Revenue (INR)
2026	2.73B
2025	2.88B
2024	2.41B
2023	3.14B
2022	2.79B
2021	2.31B
2020	456.32M
2019	135.95M
2018	0
2017	-6.14M

Net Income (INR) · A

BALAXI.NS Net Income (INR) by year
Period	Net Income (INR)
2026	14.17M
2025	250.7M
2024	-23.87M
2023	-169.14M
2022	476.58M
2021	381.36M
2020	61.04M
2019	19.66M
2018	-7.7M
2017	-7.91M

Operating Income (INR) · A

BALAXI.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	83.03M
2025	288.21M
2024	419.94M
2023	407.57M
2022	546.64M
2021	443.49M
2020	105.15M
2019	26.94M
2018	-7.7M
2017	-7.51M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Balaxi Pharmaceuticals Limited

Video analysis: BALAXI.NS

News: BALAXI.NS

Similar companies